EXPANDING TREATMENT CHOICES FOR CANCER PATIENTS
AI-powered solutions to aid healthcare professionals in selecting the most appropriate treatments at an early stage
INFORMATICS BASED
CANCER CONSULTATIONS
QGCT is a molecular analytics solution designed to examine tumor gene co-expression patterns and interaction networks from tissue-derived data, helping healthcare and research professionals generate deeper insights into cancer biology.
By analyzing more than 20,000 genes and their network relationships, QGCT supports interpretation of complex molecular profiles and enables more informed evaluation in precision oncology and translational research settings.
Quantitative Gene Co-expression Test (QGCT)
QGCT is a molecular analytics solution designed to examine tumor gene co-expression patterns and interaction networks from tissue-derived data, helping healthcare and research professionals generate deeper insights into cancer biology.
By analyzing more than 20,000 genes and their network relationships, QGCT supports interpretation of complex molecular profiles and enables more informed evaluation in precision oncology and translational research settings.
Shop Now
BOOK A QGCT® CONSULTATION now
Speak with our clinical team to learn how the QGCT® test can provide personalized insights for your cancer diagnosis and treatment options.
40+ YEARS OF FOUNDATIONAL SCIENCE
Backed by over 40 years of foundational scientific research, BYQMed leverages AI and big data to analyze the complete gene co-expression network — enabling truly personalized cancer diagnosis and treatment strategies for patients in Hong Kong and beyond.
GET IN TOUCH
WITH US now
Reach out to our team. We're here to answer your questions about the QGCT® test and guide you toward personalized cancer care.